Investigator-initiated clinical trial to be started at Northwestern University as one of our U.S. initiatives for the treatment (RS5614) of lung injuries associated with COVID-19 infections ( NCT04634799).

Click here to read the National Institute of Health’s (HIN) National Library of Medicine clinical trials database registry.

Click here for more information on our COVID-19 therapeutic candidate development project(RS5614).